Skip to content

Clinical trials

Enrolling by invitation Observational Carcinoma, Non-Small-Cell Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Observational Status: Enrolling by invitation Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20111
20191
20232
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Chest Hospital2
A2 Biotherapeutics Inc.1
Azienda Ospedaliero, Universitaria Pisana1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental1
Ming Yang1
National Cancer Institute (NCI)1
Peking University Third Hospital1
Persephone Biosciences1
Qianfoshan Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung14
Colorectal Neoplasms3
Lung Neoplasms3
Melanoma2
Mesothelioma2
Neoplasm Metastasis2
Small Cell Lung Carcinoma2
Brain Neoplasms1
Breast Neoplasms1
Cachexia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.